Benefit of denosumab therapy in patients with bone metastases from castrate resistant prostate cancer: a Number-Needed-to-Treat (NNT) Analysis
- Tammela, T. (Speaker)
Activity: Talk or presentation › Conference presentation
Activity: Talk or presentation › Conference presentation